The CoronaVac vaccine has already been given to key groups deemed to be at higher risk of exposure to the virus.. Read more at straitstimes.com.
The CoronaVac vaccine has already been given to key groups deemed to be at higher risk of exposure to the virus.. Read more at straitstimes.com.
Sinovac Biotech said on Saturday that its unit's COVID-19 vaccine has been formally approved for use by the general public by China's medical ...
It marks the second vaccine approved for public use in China.
Sinovac Biotech said on Saturday that its unit's COVID-19 vaccine has been formally approved for use by the general public by China's medical products regulator.
This week has seen a flurry of good news from COVID-19 vaccine developers, with Pfizer Inc. and BioNTech SE trumpeting early data indicating their mRNA candidate is more than 90% effective.
Chinese regulators granted a first approval for general use to a COVID-19 vaccine to China National Biotec Group’s (CNBG) BBIBP-CorV. “The NMPA granted conditional approval to the vaccine ...
Chinese company’s investigational vaccine reported to be 78% effective.
Sinovac Biotech Ltd's coronavirus vaccine candidate CoronaVac was approved in July for emergency use as part of a programme in China to vaccinate high-risk groups such as medical staff, a ...
BEIJING, April 14 (Xinhua) -- China has approved two COVID-19 inactivated vaccine candidates for clinical trials, according to the State Council joint prevention and control mechanism ...
The country’s drug regulator has given provisional approval to a Covid-19 vaccine developed by Chinese drugmaker Sinovac Biotech, which has faced questions over its vaccine efficacy due to ...
A leading Chinese COVID-19 vaccine developed by Sinovac Biotech was just 50.38 per cent effective in late-stage trials in Brazil, significantly lower than earlier results showed, according ...
A leading Chinese Covid-19 vaccine developed by Sinovac Biotech was just 50.38% effective in late-stage trials in Brazil, significantly lower than earlier results showed, according to a ...
The document by the company said that it was “advisable” for recruits aged over 50 to participate in the trial as "it may take many months" before a government-approved vaccine is ...
Here's a quick guide to the COVID-19 vaccines now in use around the world.
Everything we know so far about the race to deliver vaccines to help end the coronavirus pandemic
A little over a week after Sinopharm nabbed the world’s first full approval from Chinese regulators on a 79% efficacy showing for its COVID-19 vax, fellow Chinese native Sinovac, using ...
China’s national regulator has approved Sinovac Biotech’s coronavirus vaccine for use by the general public.
mRNA vaccines were the first to be authorized, and pivotal data show them to still be the most effective as a sixth COVID-19 vaccine reads out.
Another Chinese company is touting an early clinical win for its experimental COVID-19 vaccine. Two doses of Sinovac Biotech's COVID-19 vaccine candidate, dubbed CoronaVac, triggered an ...